Why tryptophan hydroxylase is difficult to purify: A reactive oxygen-derived species-mediated phenomenon that may be implicated in human pathology

General Pharmacology

Volumn 30, Issue 4, 1998, Pages 569-574

  Cash, Christopher D ^a  

^a CENTRE DE NEUROCHIMIE   (France)

Author keywords

Free radicals; Neuronal degeneration; Reactive oxygen species; Serotonergic system; Tryptophan hydroxylase

Indexed keywords

FREE RADICAL; ISOENZYME; REACTIVE OXYGEN METABOLITE; TRYPTOPHAN HYDROXYLASE;

ANIMAL TISSUE; BRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PURIFICATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TECHNIQUE;

EID: 0032054921     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(97)00308-X     Document Type: Article

References (79)

1. Aksenov M. U., Aksenov M. V., Harris M. E., Hensly K., Butterfield D. A., Carney J. M. Enhancement of β-amyloid peptide Aβ(1-40)-mediated neurotoxicity by glutamine synthetase. J. Neurochem. 65:1995;1899-1902.
2. 2-MPTP on serotonergic and noradrenergic nerve terminals. Mol. Pharmacol. 50:1996;1511-1519.
3. Beckman J. S., Beckman T. W., Chen J., Marshall P. A., Freeman B. A. Apparent hydroxyl radical production by peroxynitrite. implications for endothelial injury from nitric oxide and superoxide Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
4. Benton D., Cook R. Selenium supplementation improves mood in a double-blind crossover trial. Psychopharmacology. 102:1990;549-550.
5. Brannan T. S., Maker H. S., Raes I. P. Regional distribution of catalase in the adult rat brain. J. Neurochem. 36:1981;307-309.
6. Brannan T. S., Maker H. S., Weiss C., Cohen G. Regional distribution of glutathione peroxidase in the adult rat brain. J. Neurochem. 35:1980;1012-1014.
7. Bullard W. P., Capson T. L. Steady-state kinetics of bovine striatal tyrosine hydroxylase. Mol. Pharmacol. 23:1982;104-111.
8. Burns J. A., Butler J. C., Moran J., Whitesides G. M. Selective reduction of disulfides by tris(carboxyethyl)phosphine. J. Org. Chem. 56:1991;2648-2650.
9. Cadet J. L. A unifying theory of movement and madness. involvement of free radicals in disorders of the isodendritic core of the brainstem Med. Hypotheses. 27:1988;59-63.
10. Carrillo M., C. Kitani K., Kanai S., Sato Y., Miyaska K., Ivy G. O. The effect of long term (6 months) treatment with (-)deprenyl on antioxidant enzyme activities in selective brain regions in old female Fischer 344 rats. Biochem. Pharmacol. 47:1994;1333-1338.
11. Cash C. D. What is the role of the gamma-hydroxybutyrate receptor? Med. Hypotheses. 47:1996;455-459.
12. Cash C. D. Are the reactive oxygen-derived species (ROS) interactive properties of the many therapeutic drugs from various categories pertinent to their beneficial effects? Gen. Pharmacol. 28:1997;169-175.
13. Cash C. D., Vayer P., Mandel P., Maitre M. Tryptophan hydroxylase. Rapid purification from whole rat brain and production of a specific antiserum. Eur. J. Biochem. 149:1985;239-245.
14. Cash C. D., Ehret M. and Maitre M. (1986) Rat brain tryptophan hydroxylase: purification, activation and stablisation. In Progress in Tryptophan and Serotonin Research (Edited by Bender D. A., Joseph M. H. and Steinhart H.), pp. 13-18. Walter de Gruyter, Berlin, New York.
15. Chédotal A., Hamel E. Serotonin-synthesizing nerve fibers in rat and cat cerebral arteries and arterioles. immunocytochemistry of tryptophan-5-hydroxylase Neurosci. Lett. 116:1990;269-274.
16. Chen Q., Olashaw N., Wu J. Participation of reactive oxygen species in the lysophosphatidic acid-stimulated mitogen-activated protein kinase kinase pathway. J. Biol. Chem. 270:1995;28499-28502.
17. Clancy R. M., Levatovsky-Piziak J., Yegudin J., Abramson S. B. Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils. Evidence for S-nitrosoglutathione as a bioactive intermediary Proc. Natl. Acad. Sci. USA. 91:1994;3680-3684.
18. Colado M. I., Green A. R. A study of the mechanism of MDMA ("ecstasy")-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocipline and other protective compounds. Br. J. Pharmacol. 111:1994;131-136.
19. Commins D. L., Axt K. J., Vosmer G., Seiden L. S. 5,6-Dihydroxytryptamine, a serotonergic neurotoxin, is formed endogenously in the rat brain. Brain Res. 403:1987;7-14.
20. Cotton R. G. H. A pteridine adsorbant for affinity chromatography. FEBS Lett. 44:1974;290-292.
21. 14C] aminobutyric acid uptake. J. Neurochem. 47:1986;1804-1813.
22. Docherty M., Bradford H. F., Cash C. D., Ehret M., Maitre M., Joh T. H. Isolation of monoamine synaptosomes by immunomagnetophoresis. J. Neurochem. 56:1991;1569-1580.
23. Ebadi M., Srinivasan S. K., Baxi M. D. Oxidative stress and therapy in Parkinson's disease. Prog. Neurobiol. 48:1996;1-19.
24. 2+/calmodulin-dependent protein kinase. J. Neurochem. 52:1989;1886-1891.
25. Fishman J. B., Rubins J. B., Chen J. C., Dickey B. F., Volicer L. Modification of brain guanine nucleotide-binding regulatory proteins by tryptamine-4,5-dione, a neurotoxic derivative of serotonin. J. Neurochem. 56:1991;1851-1854.
26. Geronikaki A. A., Hadjipavlou-Litina D. J. In vitro studies of some 2,4-disubstituted thiazolyl-aminoketones with anti-inflammatory activity. Correlations with lipophilicity and structural characteristics. Drug Res. 46:1996;1134-1137.
27. Haavik J., Almås B., Flatmark T. Generation of reactive oxygen species by tyrosine hydroxylase. a possible contribution to the degeneration of dopaminergic neurons J. Neurochem. 68:1997;328-332.
28. Haenen G. R. M. M., de Rooij B. M., Vermeulen N. P. E., Bast A. Mechanism of the reaction of ebselin with endogenous thiols. dihydrolipoate is a better cofactor than glutathione in the peroxidase activity of ebselen Mol. Pharmacol. 37:1988;2267-2271.
29. Halliwell B. Use of desferrioxamine as a "probe" for iron-dependent formation of hydroxyl radicals. Evidence for a direct reaction between desferal and the superoxide radical. Biochem. Pharmacol. 34:1990;229-233.
30. 2+-induced proteolytic activation of tryptophan hydroxylase from the rat brainstem. J. Neurochem. 32:1979;1837-1844.
31. 2+ of tryptophan hydroxylase from the rat brain. Neurochem. Res. 3:1978;585-598.
32. Han J., Yen S., Han P. Quantification of hydrogen peroxide using tris(2-carboxyethyl)phosphine. Anal. Biochem. 234:1996;107-109.
33. 2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem. J. 281:1992;627-630.
34. Heyes M. P., Achim C. L., Wiley C. A., Major E. O., Saito K., Markey S. P. Human microglia convert L-tryptophan into the neurotoxin quinolinic acid. Biochem. J. 320:1996;595-597.
35. Hirata H., Ladenheim B., Rothman R. B., Epstein C., Cadet J. L. Methamphetamine-induced neurotoxicity is mediated by superoxide radicals. Brain Res. 677:1995;345-347.
36. Hoshi K., Yamamoto A., Fujino S. Changes in the rat brain lipid peroxidation by phenobarbital, amitriptyline, chlorpromazine or perphenazine. Res. Commun. Psychol. Psychiatry Behav. 17:1992;39-44.
37. Hufton S. E., Jennings I. G., Cotton R. G. H. Structure and function of the aromatic amino acid hydroxylases. Biochem. J. 311:1995;353-366.
38. Johansen P. A., Jennings I., Cotton R. G. H., Kuhn D. M. Phosphorylation and activation of tryptophan hydroxylase by exogenous protein kinase A. J. Neurochem. 66:1996;817-823.
39. Kaur H. A water soluble C-nitroso-aromatic spin-trap-3,5-dibromo-4-nitrosobenzene suphonic acid. The Perkins spin-trap Free Radical Res. 24:1996;409-420.
40. Kita Y., Hirasawa Y., Fukuyama S., Maeda K., Nishio M., Yoshida K. Spontaneous nitric oxide-release accounts for the potent pharmacological actions of FK409. Eur. J. Pharmacol. 257:1994;123-130.
41. Kiuchi K., Titani K., Fujita K., Suguki K., Nagatsu T. Limited proteolysis of tyrosine hydroxylase by Ca2+-activated neutral protease (calpain). Biochemistry. 30:1991;10416-10419.
42. Kuhn D., Arthur R. E. Inactivation of tryptophan hydroxylase by nitric oxide. enhancement by tetrahydrobiopterin J. Neurochem. 68:1997;1495-1502.
43. Le Prince G., Delaere P., Fages C., Lefrançois T., Touret M., Salanon M., Tardy M. Glutamine synthetase (GS) expression is reduced in senile dementia of the Alzheimer type. Neurochem. Res. 20:1995;859-862.
44. Lieberman A. Dopamine agonists used as monotherapy in de novo PD patient. comparison with selegiline Neurology. 42(suppl. 4):1992;37-40.
45. Lohr J. B., Browning J. A. Free radical involvement in neuropsychiatric illnesses. Psychopharmacol. Bull. 31:1995;159-165.
46. Lohr J. B., Caligiuri M. P. A double-blind placebo-controlled study of vitamin E treatment of tardive diskinesia. J. Clin. Psychiatry. 57:1996;167-173.
47. Lovell M. A., Ehmann W. D., Butler S. M., Markesbery W. R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology. 45:1995;1594-1601.
48. Mehdi S., Angelastro M. R., Wiseman J. S., Bey P. Inhibition of the proteolysis of rat erythrocyte proteins by a synthetic inhibitor of calpain. Biochem. Biophys. Res. Commun. 157:1988;1117-1123.
49. 3H] spiperone binding consequent to lipid peroxidation in rat cortical membranes. Biochem. Biophys. Res. Commun. 104:1982;1003-1010.
50. Müller A., Cadenas E., Graf P., Sies H. A novel biologically active seleno-organic compound-1. Glutathione peroxidase-like activity in vitro and antioxidant capacity pf PZ 51 (ebselin). Biochem. Pharmacol. 33:1984;3235-3239.
51. Murray T. K., Williams J. L., Misra A., Green A. R. The spin trap reagent PBN attenuates degeneration pf 5-HT neurones in rat brain induced by ρ-chloroamphetamine but not by fenfluramine. Neuropharmacology. 35:1996;1615-1620.
52. Nakata H., Fujisawa H. Purification and properties of tryptophan 5-monooxygenase from rat brain-stem. Eur. J. Biochem. 122:1982;41-47.
53. Nowak D., Antczak M., Król M., Bialasiewicz P., Pietras T. Antioxidant properteis of ambroxol. Free Radical Biol. Med. 16:1994;517-522.
54. Okuda S., Nishiyama N., Saito H., Katsuki H. Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine. Proc. Natl. Acad. Sci. USA. 93:1996;12553-12558.
55. Olivier C. N., Starke-Reed P. E., Stadtman E. R., Liu G. L., Carney J. M., Floyd R. A. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc. Natl. Acad. Sci. USA. 87:1990;5144-5147.
56. Peroukta S. J. Molecular biology of serotonin (5-HT) receptors. Synapse. 18:1994;241-260.
57. Pierrefiche G., Topall G., Henriet I., Laborit H. Protective effects of gammahydroxygutyrate on alloxan induced diabetes in mice. Res. Commun. Pathol. Pharmacol. 71:1991;309-319.
58. Posmantur P., Kampel A., Siman R., Liu S. J., Zhao X., Clifton G. L., Hayes R. L. A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat. Neuroscience. 77:1997;875-888.
59. Pou S., Pou W. S., Bredt D. S., Snyder S. H., Rosen G. M. Generation of superoxide by purified nitric oxide synthase. J. Biol. Chem. 267:1992;24173-24176.
60. Rafalowska U., Liu G. J., Floyd R. A. Peroxidation induced changes in synaptosomal transport of dopamine and γ-aminobutyric acid. Free Radical Biol. Med. 6:1989;485-492.
61. Ramsey A. J., Hillas P. J., Fitzpatrick P. F. Characterization of the active site iron in tyrosine hydroxylase. Redox states of the iron. J. Biol. Chem. 271:1996;24395-24400.
62. 2. Sorenson J. R. J. Biology of Copper Complexes. 1987;287-298 Humana Press, Clifton, NJ.
63. Richardson J. S., Zhou Y. Oxidative stress in the production and expression of neurotoxic β-amyloid. Restorative Neurol. Neurosci. 9:1996;207-211.
64. Richtand N. M., Inagami T., Misono K., Kuczenski R. Purification and characterization of rat striatal tyrosine hydroxylase. Comparison of the activation by cyclic AMP-dependent phosphorylation and by other effectors. J. Biol. Chem. 260:1985;8465-8473.
65. Rios C., Santamaria A. Quinolinic acid is a potent lipid peroxidant in rat brain homogenates. Neurochem. Res. 16:1991;1139-1143.
66. Saran M., Bors W. Oxygen radicals acting as chemical messengers. a hypothesis Free Radical Res. Commun. 7:1989;213-220.
67. 2-. Implication for the action of endothelium-derived relaxing factor (EDRF). Free Radical Res. Commun. 10:1990;221-226.
68. Slater A. F. G., Nobel C. S. I., Maellaro E., Bustamate J., Kimland M., Orrenius S. Nitrone spin traps and a nitroxide antioxidant inhibit a common pathway of thymocyte apoptosis. Biochem. J. 306:1995;771-778.
69. Stone D. M., Hanson G. R., Gibb J. W. In vitro reactivation of rat cortical tryptophan hydroxylase following in vivo inactivation by methylenedioxymethamphetamine. J. Neurochem. 53:1989;572-581.
70. Stone T. W., Perkins M. N. Quinolinic acid. a potent endogenous excitant at amino acid receptors in rat CNS Eur. J. Pharmacol. 72:1981;411-412.
71. ω-Hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J. Biol. Chem. 266:1991;6259-6263.
72. Tanaka M., Sotomatsu A., Yoshida T., Hirai S. Inhibitory effects of bromocriptine on phospholipid peroxidation induced by DOPA and iron. Neurosci. Lett. 183:1995;116-119.
73. Vitto A., Mandell A. J. Stability properties of activated tryptophan hydroxylase from rat midbrain. J. Neurochem. 37:1981;601-607.
74. Webber S., Harzer G., Whiteley J. M. Isolation of rat liver phenylalanine hydroxylase using a novel pteridine matrix. Anal. Biochem. 106:1980;63-72.
75. Weissman D., Belin M. F., Aguera M., Meunier C., Maitre M., Cash C. D., Ehret M., Mandel P., Pujol J. F. Immunocytochemistry of tryptophan hydroxylase in the rat brain. Neuroscience. 23:1987;291-304.
76. Wrona M. Z., Lemordant L. L., Blank L., Dryhurst G. Oxidation of 5-hydroxytryptamine. A new oxidation pathway and formation of a novel neurotoxin. J. Med. Chem. 29:1985;499-505.
77. Wrona M. Z., Yang Z., McAdams M., O'Connor-Coates S., Dryhurst G. Hydroxyl radical-mediated oxidation of serotonin. potential insights into the neurotoxicity of methamphetamine J. Neurochem. 64:1995;1390-1400.
78. Yan S. D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A. M. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.
79. Yang Z., Wrona M. Z., Dryhurst G. 5-Hydroxy-3-ethylamino-2-oxindole is not formed in rat brain following a neurotoxic dose of methamphetamine. evidence that methamphetamine does not induce the hydroxyl radical-mediated oxidation of serotonin J. Neurochem. 68:1997;1929-1941.